Forsta AP Fonden increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 86,400 shares of the medical equipment provider’s stock after acquiring an additional 200 shares during the quarter. Forsta AP Fonden’s holdings in Intuitive Surgical were worth $45,097,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of the company. State Street Corp boosted its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after buying an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. grew its position in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,749 shares of company stock valued at $15,303,875. 0.90% of the stock is currently owned by corporate insiders.
Intuitive Surgical Trading Up 0.1 %
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on ISRG. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday. Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.
View Our Latest Analysis on ISRG
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- How to Evaluate a Stock Before Buying
- 3 Steel Stocks Soaring After Tariff Announcements
- What is the Dogs of the Dow Strategy? Overview and Examples
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- What is the Hang Seng index?
- Why Salesforce Stock Could Be at Fresh Highs by February
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.